PRAX (Praxis Precision Medicines, Inc. Common Stock) Stock Analysis - Community

Praxis Precision Medicines, Inc. Common Stock (PRAX) is a publicly traded Healthcare sector company. As of May 20, 2026, PRAX trades at $335.76 with a market cap of $8.94B and a P/E ratio of -24.76. PRAX moved +4.66% today. Year to date, PRAX is +21.19%; over the trailing twelve months it is +745.37%. Its 52-week range spans $26.70 to $358.76. Analyst consensus is strong buy with an average price target of $643.38. Rallies surfaces PRAX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

How does the Rallies community trade PRAX?

Rallies community data for PRAX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.

PRAX Key Metrics

Key financial metrics for PRAX
MetricValue
Price$335.76
Market Cap$8.94B
P/E Ratio-24.76
EPS$-13.48
Dividend Yield0.00%
52-Week High$358.76
52-Week Low$26.70
Volume230.75K
Avg Volume0
Revenue (TTM)$0
Net Income$-303.27M
Gross Margin0.00%

Latest PRAX News

Recent PRAX Insider Trades

  • Nemiroff Alex sold 1.71K (~$327.14K) on Nov 20, 2025.
  • Nemiroff Alex sold 13.34K (~$2.57M) on Nov 20, 2025.
  • Nemiroff Alex sold 977 (~$188.79K) on Nov 20, 2025.

PRAX Analyst Consensus

16 analysts cover PRAX: 0 strong buy, 14 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $643.38.

Common questions about PRAX

How does the Rallies community trade PRAX?
Rallies community data for PRAX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for PRAX?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for PRAX when enough community data is available.
Is PRAX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PRAX. It does not provide personalized investment advice.
PRAX

PRAX